Juli Plc Faces Mounting Financial Pressure as Nine-Month Revenue Falls 48.2%

The pharmaceutical and consumer goods company’s third-quarter 2026 results reveal declining sales, accumulated losses and liquidity concerns, raising questions about its financial recovery prospects.

By MyReapMoney Financial Research Desk

Juli Plc is facing growing financial challenges after reporting a 48.2 per cent decline in revenue for the nine months ended September 30, 2026, reflecting weakening business performance and continuing pressure on its profitability.

Advertisement

According to the company’s third-quarter financial statements filed for the period, revenue fell to ₦198.50 million from ₦383.11 million recorded during the corresponding period of 2025.

The decline represents a reduction of approximately ₦184.62 million in turnover, highlighting the extent of the company’s sales contraction during the reporting period.

The weaker revenue performance also affected gross profit, which dropped by approximately 50 per cent to ₦64.21 million from ₦128.40 million in the previous corresponding period.

Despite reducing its administrative expenses, Juli Plc remained unable to generate sufficient gross profit to cover its operating expenditure.

Revenue decline weighs on profitability

The company’s cost of sales declined to ₦134.28 million from ₦254.71 million, broadly reflecting the contraction in turnover.

However, the reduction was insufficient to protect gross earnings.

Juli Plc’s gross profit margin declined to approximately 32.35 per cent from 33.51 per cent in the corresponding period of 2025.

This means the company retained approximately ₦32.35 from every ₦100 in sales after accounting for the direct cost of goods sold.

The pressure became more evident when administrative expenses were considered.

Administrative expenses stood at ₦107.89 million, representing a 40.7 per cent reduction from ₦182.07 million reported in the corresponding nine-month period of 2025.

Nevertheless, the expenditure remained significantly above the company’s gross profit.

Consequently, Juli Plc reported a deficit of approximately ₦43.67 million, compared with a deficit of ₦53.66 million in the previous corresponding period.

While the nine-month deficit improved by approximately 18.6 per cent, the company has yet to return to profitability.

Third-quarter performance deteriorates

The company’s performance during the third quarter raises additional concerns.

Revenue for the three months ended September 2026 declined to ₦51.64 million from ₦113.87 million in the corresponding quarter of 2025.

Gross profit dropped to ₦15.49 million from ₦39.28 million, while administrative expenses amounted to ₦46.11 million.

The resulting quarterly deficit increased to approximately ₦30.62 million from ₦22.51 million recorded in the corresponding quarter of 2025.

This indicates that the company’s quarterly performance deteriorated despite management’s efforts to reduce expenditure.

The development suggests that restoring sales and improving operating efficiency will be critical to the company’s financial recovery.

Pharmaceutical business remains central to revenue

The company’s revenue disclosure shows that pharmaceuticals remain its principal business segment.

For the third quarter, pharmaceutical sales contributed approximately ₦46.77 million, while household consumer goods generated ₦4.87 million.

Pharmaceuticals accounted for approximately 90.6 per cent of the reported quarterly turnover.

This concentration makes the performance of the pharmaceutical business particularly important to the company’s overall financial outlook.

Management will need to address the factors affecting sales, inventory availability, distribution and market competitiveness if the company is to restore revenue growth.

Asset base contracts as accumulated losses deepen

Juli Plc’s statement of financial position shows that total assets declined to ₦138.62 million as at September 30, 2026, from ₦218.04 million at the end of December 2025.

This represents a contraction of approximately 36.4 per cent.

Goodwill stood at ₦107.06 million, accounting for approximately 77.2 per cent of reported total assets.

The goodwill balance declined from ₦151.77 million in December 2025, a reduction of approximately ₦44.71 million.

The significant concentration of assets in goodwill raises questions about the company’s asset quality and the recoverability of the balance.

Inventory also declined to ₦25.02 million from ₦46.91 million, while cash and cash equivalents reduced to ₦5.54 million from ₦7.62 million.

The reduction in cash holdings, combined with declining revenue, highlights the importance of effective working capital management.

Negative shareholders’ equity raises concerns

One of the most significant issues in the financial statements is the company’s negative shareholders’ equity of approximately ₦47.99 million.

Retained earnings stood at negative ₦885.23 million, compared with negative ₦864.04 million in December 2025.

The accumulated losses have substantially eroded the company’s reported capital base.

The company also reported a term loan of ₦114.06 million, compared with ₦92.44 million in the previous year-end statement.

The increase in reported borrowing comes at a time when the company is experiencing declining sales and continuing losses.

This raises questions about its debt-servicing capacity and the sustainability of its financial structure.

Financial reporting inconsistencies require clarification

Beyond the operating challenges, Juli Plc’s published financial statements contain inconsistencies that investors should not overlook.

The reported term loan in the statement of financial position does not agree with the accompanying loan note.

The inventory figure in the main statement also differs from the supporting inventory note.

Additionally, the cash flow statement reports a negative closing cash balance of approximately ₦4.34 million, whereas the statement of financial position reports positive cash and cash equivalents of ₦5.54 million.

There are also differences in the reporting periods and loss figures presented in the cash flow statement.

These discrepancies require clarification and reconciliation by the company’s management.

Until the company provides adequate explanations, investors should exercise caution when interpreting the reported financial position.

Outlook: Recovery will depend on sales growth and financial discipline

Juli Plc’s nine-month 2026 performance presents a difficult picture of declining revenue, weakened profitability and pressure on its financial position.

Although administrative expenditure has declined, the company needs to achieve stronger sales growth and improve its operating margins to establish a sustainable recovery.

Its ability to manage debt, improve cash generation, maintain adequate inventory and address accumulated losses will also be important.

For shareholders and prospective investors, the next reporting period will be particularly important in determining whether management can reverse the current operating trend.

MyReapMoney Financial Assessment: Juli Plc faces significant financial and operational challenges. Its declining revenue, negative shareholders’ equity and liquidity concerns warrant close monitoring. The inconsistencies in its published financial statements also make further clarification necessary before a definitive investment assessment can be made.

Source: Juli Plc, Third Quarter Financial Statements for the nine months ended September 30, 2026.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *